Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Asset Writedowns and Impairment (2023 - 2025)

10x Genomics (TXG) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $114000.0 as the latest value for Q1 2025.

  • Quarterly Asset Writedowns and Impairment fell 95.35% to $114000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $714000.0 through Dec 2025, down 76.62% year-over-year, with the annual reading at $814000.0 for FY2025, 73.35% down from the prior year.
  • Asset Writedowns and Impairment hit $114000.0 in Q1 2025 for 10x Genomics, down from $600000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $7.1 million in Q4 2023 to a low of $114000.0 in Q1 2025.
  • Historically, Asset Writedowns and Impairment has averaged $2.6 million across 3 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Asset Writedowns and Impairment: tumbled 91.5% in 2024 and later plummeted 95.35% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $7.1 million in 2023, then crashed by 91.5% to $600000.0 in 2024, then plummeted by 81.0% to $114000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for TXG at $114000.0 in Q1 2025, $600000.0 in Q4 2024, and $2.5 million in Q1 2024.